Granite Point Capital Management, L.P. - Q3 2018 holdings

$1.51 Billion is the total value of Granite Point Capital Management, L.P.'s 116 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 176.2% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$239,844,000
+420.1%
825,000
+385.3%
15.91%
+285.1%
QQQ BuyPowerShares QQQ Trust, Series 1 (ETF)put$133,769,000
+73.2%
720,000
+60.0%
8.88%
+28.3%
TLT NewISHARES TRcall$93,816,000800,000
+100.0%
6.22%
XLV NewSELECT SECTOR SPDR TRput$66,605,000700,000
+100.0%
4.42%
MJ NewETF MANAGERS TRput$63,079,0001,575,000
+100.0%
4.18%
XBI BuySPDR SERIES TRUSTput$47,935,000
+30.8%
500,000
+29.9%
3.18%
-3.1%
XLF NewSELECT SECTOR SPDR TRcall$38,612,0001,400,000
+100.0%
2.56%
QQQ BuyPowerShares QQQ Trust, Series 1 (ETF)call$37,158,000
+621.5%
200,000
+566.7%
2.46%
+434.7%
ASHR NewDBX ETF TRcall$29,786,0001,175,000
+100.0%
1.98%
GLD NewSPDR GOLD TRUSTcall$25,371,000225,000
+100.0%
1.68%
KWEB NewKRANESHARES TRcall$24,410,000500,000
+100.0%
1.62%
XLB NewSELECT SECTOR SPDR TRcall$23,172,000400,000
+100.0%
1.54%
FB NewFACEBOOK INCcall$16,446,000100,000
+100.0%
1.09%
MLCO NewMELCO RESORT ENTERTAINMENT Lcall$11,633,000550,000
+100.0%
0.77%
TNDM NewTANDEM DIABETES CARE INCcall$10,710,000250,000
+100.0%
0.71%
WFC NewWELLS FARGO CO NEWcall$10,532,000200,000
+100.0%
0.70%
OIH NewVANECK VECTORS ETF TRcall$10,076,000400,000
+100.0%
0.67%
MRNS BuyMARINUS PHARMACEUTICALS INCcall$8,780,000
+780.6%
878,000
+522.7%
0.58%
+553.9%
FB BuyFACEBOOK INCcl a$5,962,000
+7.1%
36,250
+26.5%
0.40%
-20.6%
IMXI NewINTERNATIONAL MNY EXPRESS IN$4,808,000400,000
+100.0%
0.32%
YRD BuyYIRENDAI LTDsponsored adr$3,588,000
+69.1%
195,000
+95.0%
0.24%
+25.3%
NDLS BuyNOODLES & CO$3,328,000
+20.2%
275,000
+22.2%
0.22%
-10.9%
BBGI NewBEASLEY BROADCAST GROUP INCcl a$3,105,000450,000
+100.0%
0.21%
EVER NewEVERQUOTE INC$2,862,000192,600
+100.0%
0.19%
RUBY NewRUBIUS THERAPEUTICS INC$2,849,000118,700
+100.0%
0.19%
MTSI BuyMACOM TECH SOLUTIONS HLDGS I$2,785,000
+4.9%
135,200
+17.4%
0.18%
-22.3%
JT BuyJIANPU TECHNOLOGY INCadr$2,516,000
-19.7%
514,492
+8.5%
0.17%
-40.6%
MRNS NewMARINUS PHARMACEUTICALS INCput$2,500,000250,000
+100.0%
0.17%
ULTA BuyULTA BEAUTY INC$2,257,000
+93.4%
8,000
+60.0%
0.15%
+42.9%
MOMO BuyMOMO INCadr$2,212,000
+58.9%
50,500
+57.8%
0.15%
+17.6%
NewLUMENTUM HLDGS INCnote 0.250% 3/1$2,035,0001,700,000
+100.0%
0.14%
ARGX NewARGENX SEsponsored adr$1,889,00025,000
+100.0%
0.12%
BILI BuyBILIBILI INCspons ads rep z$1,887,000
+68.6%
140,000
+75.0%
0.12%
+25.0%
DB NewDEUTSCHE BANK AGcall$1,704,000150,000
+100.0%
0.11%
NVDA BuyNVIDIA CORP$1,630,000
+34.9%
5,800
+13.7%
0.11%0.0%
QNST BuyQUINSTREET INC$1,628,000
+28.2%
120,000
+20.0%
0.11%
-5.3%
VRAY NewVIEWRAY INC$1,591,000170,000
+100.0%
0.11%
BIDU BuyBAIDU INCspon adr rep a$1,555,000
+28.0%
6,800
+36.0%
0.10%
-5.5%
OPNT NewOPIANT PHARMACEUTICALS INC$1,340,00075,000
+100.0%
0.09%
TA NewTRAVELCENTERS AMER LLC$1,140,000200,000
+100.0%
0.08%
HTGM NewHTG MOLECULAR DIAGNOSTICS IN$1,010,000200,000
+100.0%
0.07%
VIAV BuyVIAVI SOLUTIONS INC$1,002,000
+37.8%
88,400
+24.5%
0.07%
+1.5%
HEAR NewTURTLE BEACH CORP$997,00050,000
+100.0%
0.07%
TPIC NewTPI COMPOSITES INC$914,00032,000
+100.0%
0.06%
USAT NewUSA TECHNOLOGIES INC$900,000125,000
+100.0%
0.06%
VNET New21VIANET GROUP INCsponsored adr$808,00080,000
+100.0%
0.05%
YY NewYY INC$599,0008,000
+100.0%
0.04%
WUBA New58 COM INCspon adr rep a$589,0008,000
+100.0%
0.04%
ESTA NewESTABLISHMENT LABS HLDGS INC$545,00022,600
+100.0%
0.04%
EGAN NewEGAIN CORP$468,00057,800
+100.0%
0.03%
FNSR BuyFINISAR CORP$381,000
+41.1%
20,000
+33.3%
0.02%
+4.2%
QD BuyQUDIAN INCadr$365,000
+3.1%
70,000
+75.0%
0.02%
-25.0%
LX BuyLEXINFINTECH HLDGS LTDadr$330,000
+103.7%
33,239
+151.8%
0.02%
+46.7%
ARLO NewARLO TECHNOLOGIES INC$290,00020,000
+100.0%
0.02%
VIPS BuyVIPSHOP HLDGS LTDsponsored adr$281,000
+72.4%
45,000
+200.0%
0.02%
+26.7%
PPDF NewPPDAI GROUP INCsponsored adr$269,00050,000
+100.0%
0.02%
PDD NewPINDUODUO INCsponsored ads$263,00010,000
+100.0%
0.02%
CTK NewCOOTEK CAYMAN INCsponsored ads$236,00025,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
META PLATFORMS INC37Q1 20233.9%
AMAZON COM INC33Q1 20235.9%
ALIBABA GROUP HLDG LTD30Q1 20231.7%
TAL EDUCATION GROUP28Q4 20220.9%
ISHARES TR27Q2 202255.1%
ALPHABET INC25Q1 20232.7%
APPLE INC25Q1 20232.3%
AXOGEN INC24Q1 20222.5%
RINGCENTRAL INC24Q4 20220.7%
ADVANCED MICRO DEVICES INC22Q1 20238.5%

View Granite Point Capital Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Granite Point Capital Management, L.P. Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Neuronetics, Inc.Sold outJanuary 26, 202200.0%
Sientra, Inc.February 12, 20212,396,0004.7%
MARINUS PHARMACEUTICALS INCJanuary 27, 20201,368,8111.6%

View Granite Point Capital Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-07
13F-HR2023-08-10
13F-HR2023-05-11
13F-HR2023-02-07
13F-HR2022-11-04
13F-HR2022-08-05
13F-HR2022-05-11
13F-HR2022-02-11
SC 13G/A2022-01-26
13F-HR2021-11-10

View Granite Point Capital Management, L.P.'s complete filings history.

Compare quarters

Export Granite Point Capital Management, L.P.'s holdings